Telegraph.co.uk |
Brain-dead pregnant woman being kept alive for her baby – against her wishes …
Telegraph.co.uk Brain death is the ceasing of all neurological activity, even if other functions can be artificially maintained. When Munoz’s family were told she was brain dead they made arrangements to honour her wish not to be kept on life support; the hospital … |
Lithium Treatment May Ease Acute Kidney Injury – Renal and Urology News
Science World ReportLithium Treatment May Ease Acute Kidney InjuryRenal and Urology NewsThe mood stabilizer lithium promotes the recovery of renal function and repair in mouse models of acute kidney injury (AKI), according to a study published online i…
Mismatched Organ Size Tied to Worse Heart Transplant Outcome – Doctors Lounge
Mismatched Organ Size Tied to Worse Heart Transplant OutcomeDoctors LoungeNoting that organ allocation in heart transplantation currently incorporates only body weight, Robert M. Reed, M.D., from the University of Maryland School of Medicine in Baltimo…
Study: Kidney Cancer Patients Preserve Kidney Function With Robot-Assisted … – Science Daily (press release)
|
Study: Kidney Cancer Patients Preserve Kidney Function With Robot-Assisted …
Science Daily (press release) 13, 2014 — Patients with chronic kidney disease who received robot-assisted partial nephrectomy to treat kidney cancer have minimal loss of kidney function — a smaller amount even than patients with normal kidney function, according to researchers at … |
FDA Accepts NDA for Gilead Lymphoma Drug – Drug Discovery & Development
Drug Discovery & Development |
FDA Accepts NDA for Gilead Lymphoma Drug
Drug Discovery & Development 11, 2013, was supported by a single arm Phase 2 study (Study 101-09) evaluating idelalisib in patients with iNHL that is refractory (non-responsive) to rituximab and to alkylating-agent-containing chemotherapy. Following Gilead’s NDA submission for … US FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment …Investor’s Business Daily |
Pharmalink Completes Enrolment of Patients into Phase IIB Clinical Study … – Sacramento Bee
Pharmalink Completes Enrolment of Patients into Phase IIB Clinical Study …Sacramento Bee… or kidney transplantation. IgA nephropathy accounts for 10% of renal transplants among patients with primary glomerulonephritis in the US and between 7-20% of…
Study: Kidney cancer patients preserve kidney function with robot-assisted … – EurekAlert (press release)
|
Study: Kidney cancer patients preserve kidney function with robot-assisted …
EurekAlert (press release) DETROIT – Patients with chronic kidney disease who received robot-assisted partial nephrectomy to treat kidney cancer have minimal loss of kidney function — a smaller amount even than patients with normal kidney function, according to researchers at … |
Cell Therapeutics to reacquire rights to two anti-cancer compounds – The Pharma Letter
Cell Therapeutics to reacquire rights to two anti-cancer compoundsThe Pharma LetterCell Thera is currently accruing patients into a Phase III trial comparing Pixuvri and rituximab with gemcitabine and rituximab in the setting of aggressive B-cell NHL. …
Nine Swedish women undergo uterus transplants – CBS News
Montreal GazetteNine Swedish women undergo uterus transplantsCBS NewsLast May, doctors announced Turkish woman Derya Sert lost her pregnancy at eight weeks after doctors could not find a fetal heartbeat. Sert had undergone a uterus transplant in 2011, …
Zebra Biologics Launched to Commercialize Ground-Breaking Next Gen … – PharmiWeb.com (press release)
|
Zebra Biologics Launched to Commercialize Ground-Breaking Next Gen …
PharmiWeb.com (press release) Zebra’s mission is the commercialization of human therapeutic antibodies derived by a novel approach that allows the generation and selection of both agonist and antagonist antibodies from functional screens using a modified combinatorial library approach. Zebra Biologics launches in SDSan Diego Source (subscription) |